The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

The aim of the present study was to conduct a meta-analysis of the effectiveness of tofacitinib, a novel oral Janus kinase inhibitor, recently approved for the treatment of active rheumatoid arthritis in patients who have failed previous treatment with methotrexate (MTX) or other disease-modifying a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawalec, Paweł, Mikrut, Alicja, Wiśniewska, Natalia, Pilc, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778229/
https://www.ncbi.nlm.nih.gov/pubmed/23877486
http://dx.doi.org/10.1007/s10067-013-2329-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778229/
https://www.ncbi.nlm.nih.gov/pubmed/23877486
http://dx.doi.org/10.1007/s10067-013-2329-9

Ejemplares similares